SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 130,649.70 |
| Enterprise Value ($M) | 191,915.70 |
| Book Value ($M) | 88,497.00 |
| Book Value / Share | 15.57 |
| Price / Book | 1.48 |
| NCAV ($M) | -71,530.00 |
| NCAV / Share | -12.58 |
| Price / NCAV | -1.83 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.05 |
| Return on Assets (ROA) | 0.04 |
| Return on Equity (ROE) | 0.09 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.96 |
| Current Ratio | 1.26 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 45,861.00 |
| Assets | 208,028.00 |
| Liabilities | 117,391.00 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 63,627.00 |
| Operating Income | 16,328.00 |
| Net Income | 8,031.00 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 12,744.00 |
| Cash from Investing | 2,652.00 |
| Cash from Financing | -17,140.00 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 9,768,950 | 42,913,585 | 22.76 | |
| 9,008,680 | 40,766,042 | 22.10 | |
| 10,226,962 | 49,866,235 | 20.51 | |
| 4,857,536 | 31,932,399 | 15.21 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| NUVB – Nuvation Bio Inc. | OGN – Organon & Co. |
| PBH – Prestige Consumer Healthcare Inc. | PRGO – Perrigo Company plc |
| QGEN – Qiagen N.V. |
Financial data and stock pages provided by
Fintel.io